Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
is modeling of multiphase flows with application in green technologies; what will give you a chance to be a part of a collaborative research environment and boost your research productivity. What we
-
| Full-time/Part-time | Remote work possible DESY, with more than 2900 employees at its two locations in Hamburg and Zeuthen, is one of the world's leading research centres. Its research focuses
-
of neonatal mortality worldwide, making this research critical to improving global pediatric health outcomes. As part of this collaborative lab, you will work alongside clinicians, molecular biologists
-
to investigate epigenetic mechanisms that regulate stem cell functions. Improved understanding of stem cell regulation will contribute to fundamental knowledge about human health and likely accelerate the progress
-
://pritykinlab.princeton.edu ) develops computational methods for design and analysis of high-throughput functional genomic assays and perturbations, with a focus on multi-modal single-cell, spatial and genome editing
-
to decipher the role of sex hormones in host-microbiome interactions in the human oral mucosa. The project revolves around tissue modeling on host-pathogens interactions, multi-omics data analysis, and
-
is part of an interdisciplinary project funded by the Human Frontiers Science Program (www.hfsp.org) and involves collaboration with researchers from biology and mechanical engineering from the UK
-
General Information The Zheng Laboratory investigates the structural and functional properties of disease-related membrane proteins from prokaryotes and eukaryotes, primarily focusing
-
development for brain disorders, leveraging stem cell-derived organoid models and gene targeting tools. Our recent work demonstrated that stem cell models offer a unique opportunity to study disease phenotypes
-
the Department of Epidemiology and Cancer Control at St. Jude Children's Research Hospital. Successful candidates will work on projects related to pharmacogenomics of long-term toxicities of cancer therapy in